| Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ... Cell Death & Differentiation 25 (3), 486-541, 2018 | 5826 | 2018 |
| Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor–induced cell death MP Boldin, TM Goncharov, YV Goltseve, D Wallach Cell 85 (6), 803-815, 1996 | 3162 | 1996 |
| Tumor necrosis factor receptor and Fas signaling mechanisms D Wallach, EE Varfolomeev, NL Malinin, YV Goltsev, AV Kovalenko, ... Annual review of immunology 17 (1), 331-367, 1999 | 1745 | 1999 |
| MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 NL Malinin, MP Boldin, AV Kovalenko, D Wallach Nature 385 (6616), 540-544, 1997 | 1691 | 1997 |
| Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally EE Varfolomeev, M Schuchmann, V Luria, N Chiannilkulchai, ... Immunity 9 (2), 267-276, 1998 | 1549 | 1998 |
| A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (∗) MP Boldin, EE Varfolomeev, Z Pancer, IL Mett, JH Camonis, D Wallach Journal of Biological Chemistry 270 (14), 7795-7798, 1995 | 1474 | 1995 |
| The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination A Kovalenko, C Chable-Bessia, G Cantarella, A Israël, D Wallach, ... Nature 424 (6950), 801-805, 2003 | 1253 | 2003 |
| Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. D Aderka, H Engelmann, Y Maor, C Brakebusch, D Wallach The Journal of experimental medicine 175 (2), 323-329, 1992 | 1145 | 1992 |
| Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. H Engelmann, D Novick, D Wallach Journal of Biological Chemistry 265 (3), 1531-1536, 1990 | 923 | 1990 |
| Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease G Boka, P Anglade, D Wallach, F Javoy-Agid, Y Agid, EC Hirsch Neuroscience letters 172 (1-2), 151-154, 1994 | 776 | 1994 |
| Elevated tumour necrosis factor‐alpha (TNF‐α) biological activity in psoriatic skin lesions P Ettehadi, MW Greaves, D Wallach, D Aderka, RDR Camp Clinical & Experimental Immunology 96 (1), 146-151, 1994 | 650 | 1994 |
| A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity H Engelmann, D Aderka, M Rubinstein, D Rotman, D Wallach Journal of Biological Chemistry 264 (20), 11974-11980, 1989 | 644 | 1989 |
| Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation SQ Zhang, A Kovalenko, G Cantarella, D Wallach Immunity 12 (3), 301-311, 2000 | 613 | 2000 |
| Soluble cytokine receptors are present in normal human urine. D Novick, H Engelmann, D Wallach, M Rubinstein The Journal of experimental medicine 170 (4), 1409-1414, 1989 | 586 | 1989 |
| Self-association of the “Death Domains” of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects (∗) MP Boldin, IL Mett, EE Varfolomeev, I Chumakov, Y Shemer-Avni, ... Journal of Biological Chemistry 270 (1), 387-391, 1995 | 545 | 1995 |
| Programmed necrosis in inflammation: Toward identification of the effector molecules D Wallach, TB Kang, CP Dillon, DR Green Science 352 (6281), aaf2154, 2016 | 537 | 2016 |
| Soluble forms of tumor necrosis factor receptors (TNF‐Rs). The cDNA for the type I TNF‐R, cloned using amino acid sequence data of its soluble form, encodes both the cell … Y Nophar, O Kemper, C Brakebusch, H Englemann, R Zwang, D Aderka, ... The EMBO Journal 9 (10), 3269-3278, 1990 | 537 | 1990 |
| Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. J Weissenbach, Y Chernajovsky, M Zeevi, L Shulman, H Soreq, U Nir, ... Proceedings of the National Academy of Sciences 77 (12), 7152-7156, 1980 | 533 | 1980 |
| Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells D Wallach, M Fellous, M Revel Nature 299 (5886), 833-836, 1982 | 516 | 1982 |
| Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. H Engelmann, H Holtmann, C Brakebusch, YS Avni, I Sarov, Y Nophar, ... Journal of Biological Chemistry 265 (24), 14497-14504, 1990 | 498 | 1990 |
